Axalta Schedules Third Quarter 2025 Earnings Conference Call PHILADELPHIA, Oct. 08, 2025 (GLOBE NEWSWIRE) -- (NYSE: AXTA), a leading global coatings company, will release its third quarter 2025 financial results at 6 a.m. ET on Tuesday, October 28. The release and supporting materials will be posted to . In addition, the company will host a conference call at 8 a.m. ET on October 28. Chris Villavarayan, Chief Executive Officer and President, and Carl Anderson, Senior Vice President and Chief Financial Officer, will review the company's financial performance for the period. A live webcas...
Axalta Unveils Innovative Coatings to Support Improved Battery Safety in Electric Vehicles New coating solutions engineered for extreme heat protection and better electrical insulation for EV battery applications PHILADELPHIA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- (NYSE: AXTA), a leading global coatings company, today will unveil two innovative products at The Battery Show North America (Booth #1638), reinforcing its commitment to innovation, technical service and performance in energy storage solutions and the automotive industry value chain. The new products, Alesta® e-PRO FG Black and A...
Dr. Delson Trindade Elevated to Axalta Fellow Becoming an Axalta Fellow is the highest honor a scientist or engineer can earn within Axalta’s Global Technology Function PHILADELPHIA, Sept. 24, 2025 (GLOBE NEWSWIRE) -- (NYSE: AXTA), a leading global coatings company, has elevated Dr. Delson Trindade to the position of Axalta Fellow, as a result of his significant scientific accomplishments, technical leadership, and commercial contributions throughout his distinguished career at Axalta. Axalta Fellow is the highest honor that a scientist or engineer can earn within the company’s Global ...
Aspen Aerogels, Inc. Appoints Glenn Deegan as Chief Administrative Officer Seasoned executive brings 25+ years of legal, HR, and transactional leadership to Aspen’s executive team NORTHBOROUGH, Mass., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the "Company"), a technology leader in sustainability and thermal management solutions, today announced the appointment of Glenn Deegan as Chief Administrative Officer. Mr. Deegan will report directly to President and Chief Executive Officer Don Young and will be based at the company’s Aerogel Technology Cente...
Aspen Aerogels, Inc. to Participate in the Barclays 39th Annual Energy-Power Conference NORTHBOROUGH, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”), a technology leader in sustainability and electrification solutions, today announced that the Company is scheduled to participate in the 39th Annual Barclays Energy-Power Conference on Wednesday, September 3, to be held at the Sheraton Times Square Hotel in New York, NY. Ricardo C. Rodriguez, Chief Financial Officer & Treasurer, and Neal Baranosky, Senior Director, Head of Investor Rela...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Mid-America Apartments, L.P. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 18 August 2025 in which we reassessed the appropriateness of the ratings in th...
A director at Opko Health Inc bought 675,000 shares at 1.320USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Aspen Aerogels, Inc. Reports Second Quarter 2025 Financial Results and Recent Business Highlights $78 million in quarterly revenue resulted in 32% gross margins and ~2X Adjusted EBITDA improvement QoQCFO transition to internal successor during Q3 ensures continuation of strategic direction and executionFixed cost structure reductions are expected to drive incremental profit in the second half of the year NORTHBOROUGH, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”), a technology leader in sustainability and electrification ...
Aspen Aerogels to Participate in August Investor Conferences NORTHBOROUGH, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the "Company"), a technology leader in sustainability and electrification solutions, today announced that the Company is scheduled to participate in the following investor events in August: (i) Oppenheimer 28th Annual Technology, Internet & Communications Conference, and (ii) Canaccord Genuity 45th Annual Growth Conference. The presentation materials utilized during the conferences will be available on the Investor Relations sect...
OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2025. Highlights from the second quarter of 2025 and recent weeks include the following: Merck advanced Phase 1 Epstein-Barr virus vaccine trial (). This investigational vaccine candidate is being developed in collaboration with Merck and evaluates safety and tolerability in up to 200 h...
Axalta Releases Second Quarter 2025 Results PHILADELPHIA, July 30, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA) (“Axalta”), a leading global coatings company, announced its financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights: Second quarter net sales of $1.3 billionNet income of $110 million with a net income margin of 8.4%Record quarter for Adjusted EBITDA of $292 millionAdjusted EBITDA margin expanded 90 basis points year over year to 22.4%Diluted EPS decreased 2% to $0.50Record quarter for Adjusted Diluted EPS of $0.64, an ...
OPKO Health to Report Second Quarter 2025 Financial Results on July 31 MIAMI, July 24, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on Thursday, July 31, 2025. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on July 31 beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-re...
Aspen Aerogels, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call NORTHBOROUGH, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the "Company") today announced that Don Young, President & Chief Executive Officer, and Ricardo C. Rodriguez, Chief Financial Officer & Treasurer, expect to discuss the Company's financial results for the second quarter ended June 30, 2025, during a conference call scheduled for Thursday, August 7, 2025, at 8:30 a.m. ET. The Company also expects to release its quarterly financial results before the mark...
Axalta Schedules Second Quarter 2025 Earnings Conference Call PHILADELPHIA, July 08, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems (NYSE: AXTA), a leading global coatings company, will release its second quarter 2025 financial results at 6 a.m. ET on Wednesday, July 30. The release and supporting materials will be posted to . In addition, the company will host a conference call at 8 a.m. ET on July 30. Chris Villavarayan, Chief Executive Officer and President, and Carl Anderson, Senior Vice President and Chief Financial Officer, will review the company's financial performance for the p...
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress MIAMI and JERUSALEM, July 08, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (“OPKO”) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that their abstract “First-in-Class Oral GLP-2 Analog for Treatment of Short Bowel Syndrome” has been selected for a poster presentation at the 47th European Society for Clinical Nutrition & Metabolism (“ESPEN”) Congress, taking place September 13–16, 2025, in Prague, Czech Republic. A...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.